Catalent
CTLT
#1737
Rank
C$15.91 B
Marketcap
C$87.70
Share price
0.00%
Change (1 day)
12.11%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : C$6.83 Billion

According to Catalent's latest financial reports the company's total debt is C$6.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30C$6.43 B18.51%
2022-06-30C$5.42 B34.47%
2021-06-30C$4.03 B-1.96%
2020-06-30C$4.11 B6.28%
2019-06-30C$3.87 B8.26%
2018-06-30C$3.57 B32.45%
2017-06-30C$2.70 B12.06%
2016-06-30C$2.41 B2.73%
2015-06-30C$2.34 B-18.87%
2014-06-30C$2.89 B2.22%
2013-06-30C$2.82 B3.56%
2012-06-30C$2.73 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Supernus Pharmaceuticals
SUPN
C$58.31 M-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.46 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$7.49 B 9.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
C$0.30 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA